Health Catalyst, Inc. (NASDAQ:HCAT) Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ET
Company Participants
Jack Knight – VP, IR
Dan Burton – CEO
Dan LeSueur – COO
Jason Alger – CFO
Conference Call Participants
Jared Haase – William Blair
Jessica Tassan – Piper Sandler
Anna Kruszenski – Barclays Bank
John Pinney – Canaccord Genuity
Thomas Kelliher – RBC Capital Markets
David Larsen – BTIG
John Ransom – Raymond James
Scott Schoenhaus – KeyBanc
Stan Berenshteyn – Wells Fargo
Operator
Welcome to the Health Catalyst Third Quarter 2024 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for your questions following the presentation. [Operator Instructions]
I would now like to turn the call over to Jack Knight, Vice President of Investor Relations.
Jack Knight
Good afternoon, and welcome to Health Catalyst’s earnings conference call for the third quarter of 2024, which ended on September 30th, 2024. My name is Jack Knight, I’m the Vice President of Investor Relations for Health Catalyst. And with me on the call is Dan Burton, our Chief Executive Officer; Jason Alger, our Chief Financial Officer; and Dan LeSueur, our Chief Operating Officer.
A complete disclosure of our results can be found in our press release issued today. as well as in our related Form 8-K furnished to the SEC, both of which are available on the Investor Relations section of our website at ir.healthcatalyst.com.
As a reminder, today’s call is being recorded, and a replay will be available following the conclusion of the call. During today’s call, we will make forward-looking statements pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995 regarding our future growth and our financial outlook for the remainder of 2024 and full year 2025.
